FDA DELAYS its decision on Moderna vaccine use for children aged 12 to 17 to evaluate myocarditis risk, says firm
BROADCASTING FOR INDEPENDENCE
FDA DELAYS its decision on Moderna vaccine use for children aged 12 to 17 to evaluate myocarditis risk, says firm